Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Animal Welfare Act (1)
- Animals (1)
- Biomedical research (1)
- Biotechnology (1)
- Colleges and universities (1)
-
- Competition (1)
- Corporations (1)
- Drug Price Competition and Patent Term Restoration Act (1)
- Drug approvals (1)
- Drugs (1)
- Exclusivity (1)
- Experiments (1)
- Federal agencies (1)
- Food and Drug Administration (1)
- Industries (1)
- Patent and Trademark Office (1)
- Patent infringement (1)
- Patent law (1)
- Pharmaceuticals (1)
Articles 1 - 2 of 2
Full-Text Articles in Law
The Least Of The Sentient Beings' And The Question Of Reduction, Refinement, And Replacement, Joseph Vining
The Least Of The Sentient Beings' And The Question Of Reduction, Refinement, And Replacement, Joseph Vining
Other Publications
The subject I was asked to think about with you today is raised by a very large change in the focus of biomedical research. In raw percentage terms, the animals involved in experimentation are now overwhelmingly rats and mice, and, perhaps because they are rats and mice, they are used in large numbers, numbers in thousands and tens of thousands at some institutions. Legal, ethical, and practical accommodation to this fact on the ground presents a host of questions. There are questions of the cost of care. There are questions of the training of veterinarians, principal investigators, and laboratory personnel. …
Patents, Product Exclusivity, And Information Dissemination: How Law Directs Biopharmaceutical Research And Development, Rebecca S. Eisenberg
Patents, Product Exclusivity, And Information Dissemination: How Law Directs Biopharmaceutical Research And Development, Rebecca S. Eisenberg
Other Publications
It's a great honor for me to be invited to deliver the Levine Distinguished Lecture at Fordham, and a great opportunity to try out some new ideas before this audience. As some of you know, I've been studying the role of patents in biomedical research and product development ("R&D") for close to twenty years now, with a particular focus on how patents work in "upstream" research in universities and biotechnology companies that are working on research problems that arise prior to "downstream" product development. But, of course, the patent strategies of these institutions are designed around the profits that everyone …